000142137 000__ 01616fam\a2200337\a\4500
000142137 001__ 142137
000142137 005__ 20220217103229.0
000142137 008__ 920512s1992\\\\dcua\\\\\b\\\f000\0\eng\d
000142137 020__ $$a0160383536
000142137 035__ $$a(OCoLC)ocm25797655
000142137 035__ $$a142137
000142137 040__ $$dGPO
000142137 043__ $$an-us---
000142137 049__ $$aISEA
000142137 074__ $$a1019-A
000142137 0860_ $$aY 4.En 2/3:102-96
000142137 088__ $$aSerial no. 102-96 (United States. Congress. House. Committee on Energy and Commerce)
000142137 090__ $$aHD9000.9.U5$$bH8 1991
000142137 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Energy and Commerce.$$bSubcommittee on Oversight and Investigations.
000142137 24510 $$aFDA management and enforcement :$$bhearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, September 12, 1991.
000142137 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,$$c1992.
000142137 300__ $$aiii, 388 p. :$$bill. ;$$c24 cm.
000142137 500__ $$aDistributed to some depository libraries in microfiche.
000142137 500__ $$aShipping list no.: 92-304-P.
000142137 500__ $$a"Serial no. 102-96."
000142137 504__ $$aIncludes bibliographical references.
000142137 61010 $$aUnited States.$$bFood and Drug Administration$$xManagement.
000142137 61010 $$aUnited States.$$bDepartment of Health and Human Services$$xManagement.
000142137 650_0 $$aGeneric drugs$$xGovernment policy$$zUnited States.
000142137 650_0 $$aMedical instruments and apparatus industry$$zUnited States$$xQuality control.
000142137 650_0 $$aPharmaceutical industry$$zUnited States$$xQuality control.
000142137 85230 $$bdfich$$hY 4.EN 2/3:$$i102-96
000142137 909CO $$ooai:library.usi.edu:142137$$pGLOBAL_SET
000142137 980__ $$aBIB
000142137 980__ $$aGOV RESOURCE